J
JerryZ
Guest
Taken from:
onlinelibrary.wiley.com/journal/10.1111/(ISSN)1399-0004
onlinelibrary.wiley.com/doi/10.1111/j.1399-0004.2010.01604.x/full
onlinelibrary.wiley.com/journal/10.1111/(ISSN)1399-0004
onlinelibrary.wiley.com/doi/10.1111/j.1399-0004.2010.01604.x/full
Breast cancer after prophylactic mastectomy?
“You have breast cancer” are the last words any woman wants to hear. But women facing hereditary breast and ovarian cancer risk who opt for prophylactic mastectomies hope never to hear these words. Avoiding breast cancer is why these women take dramatic action to reduce risk. So when a new study comes out that may indicate that residual breast cancer risk is higher than previously thought, alarm bells start sounding in the high-risk community. The journal Clinical Genetics did publish such a study recently. This study, entitled Breast cancer after bilateral risk-reducing mastectomy is based on research out of Denmark involving 307 BRCA-positive women, 96 of whom chose to have prophylactic bilateral mastectomies to reduce their risk.
And I will shut up!On one level, the study’s finding are concerning. Three of the 96 women developed breast cancer 2 years, 5 years, and 7 years after prophylactic mastectomy respectively. All of these women were BRCA1 positive and all of the cancers were triple negative. These numbers led the researchers to alarming conclusion that the breast cancer risk after preventive mastectomy for BRCA-positive women is roughly 10 percent, almost the same level of risk as the average risk women.